Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma, representing
approximately one-third of all cases worldwide. In the World Health Organization (WHO) …

Opinion statement Diffuse large B cell lymphoma (DLBCL) arises from extranodal organs in
about 30% of cases. Its prognosis and risk of recurrence in the central nervous system …

Primary central nervous system (CNS) lymphoma (PCNSL) and primary testicular lymphoma
(PTL) are rare extranodal large B-cell lymphomas with similar genetic signatures. There are …

Primary central nervous system lymphomas (PCNSLs) and primary testicular lymphomas
(PTLs) are extranodal large B-cell lymphomas (LBCLs) with inferior responses to current …

The addition of rituximab has improved outcomes in diffuse large B‐cell lymphoma (DLBCL),
however, there remains limited information on the impact of rituximab in those with testicular …

Primary testicular lymphoma is a rare and aggressive lymphoid malignancy, most often
representing diffuse large B-cell lymphoma histologically. Tumor-associated macrophages …

Primary testicular diffuse large B-cell lymphoma (PTL) is characterized by high risk of
contralateral testis and central nervous system (CNS) relapse. Chemoimmunotherapy with …

The distribution and clinical impact of cell-of-origin (COO) subtypes of diffuse large B-cell
lymphoma (DLBCL) outside Western countries remain unknown. Recent literature also …

Tumor cells evade immune destruction, at least partially, by upregulating inhibitory signals to
limit effector T cell activation. Programmed death 1 (PD-1) is one of the most critical co …

Primary testicular lymphoma is a rare lymphoid malignancy, most often, histologically,
representing diffuse large B-cell lymphoma. The tumor microenvironment and limited …